Orphan, R&E tax credits under review

WASHINGTON - The oversight subcommittee of the House Ways and Means Committee will hold hearings this week on tax credits, including the Orphan Drug and Research & Experimentation credits.

On Tuesday, the subcommittee will hear testimony from Lisa Raines, vice president for governmental relations at Genzyme Corp., in

Read the full 478 word article

How to gain access

Continue reading with a
two-week free trial.